Immunomodulation of salivary gland function due to cancer therapy
Oral Diseases · 2025-09 · 31 (9) · 2680-2694
DOI: 10.1111/odi.14972 ↗At a glance
Übersichtsarbeit in Oral Diseases, published online on 2024-05-02. Written by Ana C Costa-da-Silva and 3 co-authors. Institution: Oral Immunobiology Unit, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, USA. Major MEDLINE topics: Salivary Glands, Immunomodulation, Neoplasms, Salivary Gland Diseases. Cited 4 times so far (Crossref); 100 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Intramural NIH HHS, NIH HHS, National Institutes of Health.
Abstract (original language)
Functional salivary glands (SG) are essential for maintaining oral health, and salivary dysfunction is a persistent major clinical challenge. Several cancer therapies also have off‐target effects leading to SG dysfunction. Recent advances highlight the role of SG immune populations in homeostasis, dysfunction and gland regeneration. Here, we review what is known about SG immune populations during development and postnatal homeostasis. We summarize recent findings of immune cell involvement in SG dysfunction following cancer treatments such as irradiation (IR) for head and neck cancers, immune transplant leading to graft‐versus‐host‐disease (GVHD) and immune checkpoint inhibitor (ICI) treatment. The role of immune cells in SG in both homeostasis and disease, is an emerging field of research that may provide important clues to organ dysfunction and lead to novel therapeutic targets.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Oral Immunobiology Unit, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, USA.
- Matrix and Morphogenesis Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, USA.
ORCID profiles: Marit H Aure
Funding
- Intramural NIH HHS
- NIH HHS
- National Institutes of Health
Cite
APA
Costa-da-Silva, A. C., Villapudua, C. U., Hoffman, M. P., & Aure, M. H. (2025). Immunomodulation of salivary gland function due to cancer therapy. Oral Diseases, 31(9), 2680-2694. https://doi.org/10.1111/odi.14972
Vancouver
Costa-da-Silva AC, Villapudua CU, Hoffman MP, Aure MH. Immunomodulation of salivary gland function due to cancer therapy. Oral Diseases. 2025;31(9):2680-2694. doi:10.1111/odi.14972
BibTeX
@article{CostadaSilva2025,
author = {Costa-da-Silva, Ana C and Villapudua, Carlos U and Hoffman, Matthew P and Aure, Marit H},
title = {Immunomodulation of salivary gland function due to cancer therapy},
journal = {Oral Diseases},
year = {2025},
volume = {31},
number = {9},
pages = {2680--2694},
doi = {10.1111/odi.14972}
}
EUVIMED